Drug Shortage Report for ACTEMRA

Last updated on 2022-06-23 History
Report ID 155146
Drug Identification Number 02350106
Brand name ACTEMRA
Common or Proper name ACTEMRA
Company Name HOFFMANN-LA ROCHE LIMITED
Market Status MARKETED
Active Ingredient(s) TOCILIZUMAB
Strength(s) 200MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 200MG/10ML 1VIAL
ATC code L04AC
ATC description IMMUNOSUPPRESSANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2022-07-15
Actual start date
Estimated end date 2022-07-30
Actual end date 2022-06-22
Shortage status Avoided shortage
Updated date 2022-06-23
Company comments
Health Canada comments
Tier 3 Status Yes
Contact Address 7070 MISSISSAUGA ROAD
MISSISSAUGA, ONTARIO
CANADA L5N 5M8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v22 2022-06-23 French Compare
v21 2022-06-23 English Compare
v20 2022-06-16 French Compare
v19 2022-06-16 English Compare
v18 2022-06-16 English Compare
v17 2022-05-31 French Compare
v16 2022-05-31 English Compare
v15 2022-05-31 English Compare
v14 2022-05-11 French Compare
v13 2022-05-11 English Compare
v12 2022-05-03 French Compare
v11 2022-05-03 English Compare
v10 2022-05-01 English Compare
v9 2022-04-12 French Compare
v8 2022-04-12 English Compare
v7 2022-03-31 French Compare
v6 2022-03-31 English Compare
v5 2022-03-04 French Compare
v4 2022-03-04 English Compare
v3 2022-02-23 English Compare

Showing 1 to 20 of 22